CN1212859C - Acute cystourethritis treating medicine - Google Patents

Acute cystourethritis treating medicine Download PDF

Info

Publication number
CN1212859C
CN1212859C CN 200310112052 CN200310112052A CN1212859C CN 1212859 C CN1212859 C CN 1212859C CN 200310112052 CN200310112052 CN 200310112052 CN 200310112052 A CN200310112052 A CN 200310112052A CN 1212859 C CN1212859 C CN 1212859C
Authority
CN
China
Prior art keywords
medicine
parts
raw material
acute
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200310112052
Other languages
Chinese (zh)
Other versions
CN1541695A (en
Inventor
王善柏
王洪梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200310112052 priority Critical patent/CN1212859C/en
Publication of CN1541695A publication Critical patent/CN1541695A/en
Application granted granted Critical
Publication of CN1212859C publication Critical patent/CN1212859C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention discloses medicine for treating acute cystourethritis, which is prepared from the following raw material by weight parts: 70 to 85 parts of white michelia flower, 8 to 15 parts of dandelion and 8 to 15 parts of philippine violet herb. The preparation method comprises: mixing the raw material, decocting a mixture of the raw material in water with the amount of 10 times of the amount of the raw material for 8 hours, removing dregs of decoction, filtering medicinal solution, concentrating, drying, crushing, sieving with a sieving size of 100 meshes, filling into capsules weighing 0.3 gram and bottling. The medicine of the present invention is capable of inhibiting colibacillus, and the purposes of good and rapid effect and thorough curative effect can be achieved when the medicine of the present invention is taken. Moreover, Chinese patent medicine has no side effects on the treatment of acute diseases, cost is low, and curative effects are better than those of western medicine.

Description

A kind of medicine for the treatment of acute urethrocystitis
Technical field
The present invention relates to a kind of medicine for the treatment of acute urethrocystitis.
Background technology
Acute urethrocystitis belongs to bacterial infection disease, mainly is coli-infection, and the men and women all can fall ill, but the women is more.Mainly be to use antibiotic therapy at present, because the drug-fast generation of antibacterial is thoroughly cured this sick being difficult to, make the state of an illness constantly repeatedly, bad controlling for a long time do not imitated during fashion, and the antibiotic therapy side effect is bigger.
Summary of the invention
The object of the present invention is to provide a kind of can thoroughly the healing and the medicine of the treatment acute urethrocystitis that quick-acting safety has no side effect.
For achieving the above object, the present invention's medicine for the treatment of acute urethrocystitis is made by the raw material of following weight portion: 70~85 parts of Flos micheliae Albae, 8~15 parts of Herba Taraxacis, 8~15 parts of Herba Violaes.
The present invention treats the medicine of acute urethrocystitis and is made by the raw material of following weight portion: 80 parts of Flos micheliae Albae, 10 parts of Herba Taraxacis, 10 parts of Herba Violaes.
Use the clinical effectiveness of Drug therapy of the present invention as follows:
(1) clinical case amounts to 100 examples, and wherein 6 years old of the age minimum, maximum 60 years old, all there was morbidity at the various ages, and wherein the adult accounts for 80%.The shortest two hours of disease time the longest 2 days, is acute patient.
(2) administrated method: obey every day four times, limit 6 (every 0.3 gram) at every turn, the morning, noon and afternoon and sleep before service once, serve on 3-5 days.
(3) therapeutic outcome: treatment 100 examples are all cured cure rate 100%.67 people that wherein take medicine and cured in two days; 23 people that take medicine and cured in three days; 10 people that take medicine and cured in four days.Overwhelming majority healing in 2-3 days.
(4) model case:
Example 1, patient Huang, the woman, 46 years old, during sudden onset, urgent micturition, frequent micturition, dysurea, hematuria.Check: body temperature 38 degree, leukocyte 3900, the greasy urine cell ++, erythrocyte ++.Take medicine of the present invention after one day symptom obviously alleviate, two days all transference cures of taking medicine are taken medicine and were thoroughly cured in three days.
Example 2, patient's summer, the woman, 66 years old, during sudden onset, urgent micturition, frequent micturition, dysurea, hematuria.Body temperature 38 degree, leukocyte 11000, the greasy urine cell +++, pus cell +++.The one day sx of taking medicine serve on four days, thoroughly cures, and laboratory examination is all normal.
From above-mentioned clinical proof, medicine of the present invention has the good restraining effect to escherichia coli, takes medicine of the present invention and can reach efficient, quick-acting, and curative effect is thorough.And with the Chinese patent drugs for treatment acute disease have no side effect, cost is low, surpasses the therapeutic effect of Western medicine.
The specific embodiment
Get 80 kilograms of Flos micheliae Albae, use its cured leaf; 10 kilograms of Herba Taraxacis are used its herb; 10 kilograms of Herba Violaes are used its herb, and above-mentioned raw materials mix is amounted to 100 kilograms, add the decocting eight hours of 10 times of amounts, remove slag, medical filtration, concentrate, dry, pulverized 100 mesh sieves, adorn capsule, the bottling of 0.3 gram.
Get 70 kilograms of Flos micheliae Albae, use its cured leaf; 8 kilograms of Herba Taraxacis are used its herb; 8 kilograms of Herba Violaes are used its herb, and above-mentioned raw materials mix is amounted to 86 kilograms, add the decocting five hours of 10 times of amounts, remove slag, medical filtration, concentrate, dry, pulverized 100 mesh sieves, adorn capsule, the bottling of 0.3 gram.
Get 85 kilograms of Flos micheliae Albae, use its cured leaf; 15 kilograms of Herba Taraxacis are used its herb; 15 kilograms of Herba Violaes are used its herb, and above-mentioned raw materials mix is amounted to 115 kilograms, add the decocting ten hours of 10 times of amounts, remove slag, medical filtration, concentrate, dry, pulverized 100 mesh sieves, adorn capsule, the bottling of 0.3 gram.

Claims (2)

1, a kind of medicine for the treatment of acute urethrocystitis is characterized in that being made by the raw material of following weight portion: 70~85 parts of Flos micheliae Albae, 8~15 parts of Herba Taraxacis, 8~15 parts of Herba Violaes.
2, the medicine of treatment acute urethrocystitis according to claim 1 is characterized in that being made by the raw material of following weight portion: 80 parts of Flos micheliae Albae, 10 parts of Herba Taraxacis, 10 parts of Herba Violaes.
CN 200310112052 2003-11-06 2003-11-06 Acute cystourethritis treating medicine Expired - Fee Related CN1212859C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200310112052 CN1212859C (en) 2003-11-06 2003-11-06 Acute cystourethritis treating medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200310112052 CN1212859C (en) 2003-11-06 2003-11-06 Acute cystourethritis treating medicine

Publications (2)

Publication Number Publication Date
CN1541695A CN1541695A (en) 2004-11-03
CN1212859C true CN1212859C (en) 2005-08-03

Family

ID=34336361

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200310112052 Expired - Fee Related CN1212859C (en) 2003-11-06 2003-11-06 Acute cystourethritis treating medicine

Country Status (1)

Country Link
CN (1) CN1212859C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007246429A (en) * 2006-03-15 2007-09-27 Shiratori Pharmaceutical Co Ltd Lipase inhibitor, and food and drink
CN103656435A (en) * 2013-12-19 2014-03-26 青岛中科菲力工程技术研发有限公司 Traditional Chinese medicine capsule for treating prostatitis and preparation method of capsule

Also Published As

Publication number Publication date
CN1541695A (en) 2004-11-03

Similar Documents

Publication Publication Date Title
CN101554424B (en) Traditional Chinese medicine for treating skin diseases and preparation method thereof
CN1051237C (en) Meicinal prepn. "Kexianling" for curing epilepsy
CN111297961A (en) Dong medicine for promoting wound healing
CN101143171B (en) Traditional Chinese medicine and its preparation method and its application
CN1212859C (en) Acute cystourethritis treating medicine
CN1294930C (en) Medication for treating cough caused by inflammation of upper respiratory tract
CN1686492A (en) Antibicrobial anti inflammatory capsule and its preparation method
CN1281228C (en) Medicine for hyperplasia of mammary glands and its preparation
CN103007159A (en) Chinese medicinal preparation for correcting pancreas islet function
CN1618439A (en) Broad-specturm medicine for treating snake venom poisoning
CN101229193A (en) External Chinese patent medicine for treating skin ulceration and organism gangrene
CN100560092C (en) The external Chinese medicine of treatment hepatitis B, hepatic ascites
CN1692922A (en) Medicine composite used for lowering blood-sugar, prepn. method and use thereof
CN1575803A (en) Application method of Aloe vera L. extract in preventing and curing diabetes
CN1294983C (en) Medicine for treating facial paralysis and its preparing method
CN115919918B (en) Application of luffa alcohol precipitation extract
CN1074928C (en) Medicine for curing hemiplegia and its preparing process
CN100560087C (en) Pharmaceutical composition of treatment malignant tumor and preparation method thereof
CN1173365A (en) Chinese medicinal preparation for curing rheumatism and rheumatoid disease and its prepn. method
CN1343517A (en) Medicine for treating dermatopathy and its preparing process
CN1709298A (en) Chinese medicine formulation for treating chronic prostatitis and its preparing method
CN1399985A (en) Medicine for curing rhinitis and its preparation method
CN1602921A (en) Medicine for treating diabetes and its preparing process
CN1057926C (en) Medicinal composition for curing gastrointestinal disease
CN1245181C (en) Chinese medicine of capsule (tablet) of nine ingredients for treating psoriasis and its preparing process

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee